Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Roche’s Follicular Lymphoma Therapy Scores FDA Approval

By Vandana Singh
December 23, 1:53 PM
The FDA approved Roche Holding AG (OTC:RHHBY) unit Genentech’s Lunsumio (mosunetuzumab-axgb) for relapsed or refractory (R/R) follicular lymphoma (FL) after two or more…

BIIB

Read More
2 minute read
  • Entertainment
  • General
  • Large Cap
  • Mid Cap
  • News
  • Penny Stocks
  • Topics
  • Trading Ideas

Bomb Cyclone: 200 Million People Experience Artic Chill Halting Holiday Travel

By AJ Fabino
December 23, 12:23 PM
A powerful, and windy winter storm — dubbed a "bomb cyclone" due to the plummeting barometric pressure — is blasting its way across the U.S. and Canada. affecting over 200 million people ahead of the year's busiest travel days.

GNRC

Read More
4 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Media
  • News
  • Tech
  • Top Stories

Meta Settles Cambridge Analytica Scandal Case, Microsoft Files Rebuttal To FTC’s Lawsuit Against Activision Deal, US Winter Storm Snaps Holiday Plans: Today’s Top Stories

By Vandana Singh
December 23, 9:58 AM
Reuters

$BNB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals

By Vandana Singh
December 23, 9:52 AM
According to a large study, dubbed PANORAMIC, Merck & Co Inc’s (NYSE: MRK) COVID-19 antiviral molnupiravir speeds up recovery but does…

MRK

Read More
1 minute read
  • General
  • Large Cap
  • News

United Airlines’ Pilot Union Leader Resigns Over Controversial Comments

By Vandana Singh
December 23, 8:49 AM
United Airlines Holdings Inc's (NASDAQ: UAL) Chicago-based pilot, Neil Swindells, elected to lead the United Airlines pilots' union, has resigned after a series of his recent online posts sparked an outcry. Swindells apologized "to anyone I have offended."

UAL

Read More
2 minute read
  • General
  • Large Cap
  • Legal
  • Media
  • News
  • Tech
  • Top Stories

Remember Cambridge Analytica Scandal? Facebook Parent Meta To Pay $725M To Settle Privacy Lawsuit

By Vandana Singh
December 23, 8:45 AM
The fallout from Facebook’s Cambridge Analytica privacy scandal continues four years after it was first exposed in March 2018. Parent company Meta…

META

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Approves Gilead’s New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients

By Vandana Singh
December 22, 3:01 PM
The FDA has approved Gilead Sciences Inc’s (NASDAQ:GILD) Sunlenca (lenacapavir), in combination with another antiretroviral (s) (ARV), for HIV-1 infection in…

GILD

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates

By Vandana Singh
December 22, 1:31 PM
Merck & Co Inc (NYSE:MRK) and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co Ltd) have entered into an exclusive license and collaboration…

MRK

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Government
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Moderna Finalizes 10-Year Agreement With UK Government For mRNA Vaccine Manufacturing Centre

By Vandana Singh
December 22, 12:10 PM
Moderna Inc (NASDAQ: MRNA) has finalized a strategic partnership with the U.K. government to establish an mRNA vaccine research, development, and manufacturing…

MRNA

Read More
3 minute read
  • General
  • Large Cap
  • Legal
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Tech
  • Top Stories

Tesla Boosts Discounts, SEC Tightens Check On Auditors’ Report On Crypto, Netflix Plans New Jersey Production Hub: Today’s Top Stories

By Vandana Singh
December 22, 10:27 AM
Bloomberg Tesla Boosts Discounts To Tap More US Buyers

$BNB

Posts pagination

Previous 1 … 369 370 371 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service